1887

Abstract

The identification and characterization of neutralizing anti-hepatitis C virus (HCV) antibodies may have a major impact on understanding HCV pathogenesis. However, to date, their detection has only been based on the inhibition of either the E2 envelope protein or HCV virions binding to different target cells. The permissivity of primary biliary cells for HCV infection has been demonstrated previously. In the present report, infection of biliary cells was demonstrated further by combining PCR and immunohistochemical detection of the HCV core protein. This study demonstrates, using both serum and purified IgG, the presence of neutralizing anti-HCV antibodies in the serum of patients showing long-term response to antiviral therapy. Overall, the usefulness of the primary biliary cell infection model to investigate anti-HCV neutralization is shown.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-83-7-1673
2002-07-01
2019-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jgv/83/7/0831673a.html?itemId=/content/journal/jgv/10.1099/0022-1317-83-7-1673&mimeType=html&fmt=ahah

References

  1. Abrignani, S. & Rosa, D. ( 1998; ). Perspectives for a hepatitis C virus vaccine. Clinical and Diagnostic Virology 10, 181-185.[CrossRef]
    [Google Scholar]
  2. Azzari, C., Resti, M., Moriondo, M., Ferrari, R., Lionetti, P. & Vierucci, A. ( 2000; ). Vertical transmission of HCV is related to maternal peripheral blood mononuclear cell infection. Blood 96, 2045-2048.
    [Google Scholar]
  3. Baumert, T. F., Ito, S., Wong, D. T. & Liang, T. J. ( 1998; ). Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. Journal of Virology 72, 3827-3836.
    [Google Scholar]
  4. Baumert, T. F., Wellnitz, S., Aono, S., Satoi, J., Herion, D., Tilman Gerlach, J., Pape, G. R., Lau, J. Y., Hoofnagle, J. H., Blum, H. E. & Liang, T. J. ( 2000; ). Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C. Hepatology 32, 610-617.[CrossRef]
    [Google Scholar]
  5. Blight, K. J., Kolykhalov, A. A., Reed, K. E., Agapov, E. V. & Rice, C. M. ( 1998; ). Molecular virology of hepatitis C virus: an update with respect to potential antiviral targets. Antiviral Therapy 3, 71-81.
    [Google Scholar]
  6. Bréchot, C. ( 1996; ). Hepatitis C virus: molecular biology and genetic variability. Digestive Diseases and Sciences 41, 6S-21S.[CrossRef]
    [Google Scholar]
  7. Cerny, A. & Chisari, F. V. ( 1999; ). Pathogenesis of chronic hepatitis C: immunological features of hepatic injury and viral persistence. Hepatology 30, 595-601.[CrossRef]
    [Google Scholar]
  8. Farci, P., Alter, H. J., Wong, D. C., Miller, R. H., Govindarajan, S., Engle, R., Shapiro, M. & Purcell, R. H. ( 1994; ). Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proceedings of the National Academy of Sciences, USA 91, 7792-7796.[CrossRef]
    [Google Scholar]
  9. Farci, P., Shimoda, A., Coiana, A., Diaz, G., Peddis, G., Melpolder, J. C., Strazzera, A., Chien, D. Y., Munoz, S. J., Balestrieri, A., Purcell, R. H. & Alter, H. J. ( 2000; ). The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288, 339-344.[CrossRef]
    [Google Scholar]
  10. Feray, C., Gigou, M., Samuel, D., Ducot, B., Maisonneuve, P., Reynes, M., Bismuth, A. & Bismuth, H. ( 1998; ). Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Annals of Internal Medicine 128, 810-816.[CrossRef]
    [Google Scholar]
  11. Hassoba, H. M., Terrault, N. A., el-Gohary, A. M., Scheffel, C., Jou, C., Brackett, J., Hunt, J., Lou, S. C. & Wright, T. L. ( 1997; ). Antibody to GBV-C second envelope glycoprotein (anti-GBV-C E2): is it a marker for immunity? Journal of Medical Virology 53, 354-360.[CrossRef]
    [Google Scholar]
  12. Ishii, K., Rosa, D., Watanabe, Y., Katayama, T., Harada, H., Wyatt, C., Kiyosawa, K., Aizaki, H., Matsuura, Y., Houghton, M., Abrignani, S. & Miyamura, T. ( 1998; ). High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology 28, 1117-1120.[CrossRef]
    [Google Scholar]
  13. Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J. & Hahn, Y. S. ( 2000; ). Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation. Journal of Clinical Investigation 106, 1239-1249.[CrossRef]
    [Google Scholar]
  14. Klenerman, P., Lechner, F., Kantzanou, M., Ciurea, A., Hengartner, H. & Zinkernagel, R. ( 2000; ). Viral escape and the failure of cellular immune responses. Science 289, 2003.[CrossRef]
    [Google Scholar]
  15. Lai, M. M. & Ware, C. F. ( 2000; ). Hepatitis C virus core protein: possible roles in viral pathogenesis. Current Topics in Microbiology and Immunology 242, 117-134.
    [Google Scholar]
  16. Large, M. K., Kittlesen, D. J. & Hahn, Y. S. ( 1999; ). Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence. Journal of Immunology 162, 931-938.
    [Google Scholar]
  17. Lechner, S., Rispeter, K., Meisel, H., Kraas, W., Jung, G., Roggendorf, M. & Zibert, A. ( 1998; ). Antibodies directed to envelope proteins of hepatitis C virus outside of hypervariable region 1. Virology 243, 313-321.[CrossRef]
    [Google Scholar]
  18. Lerat, H., Berby, F., Trabaud, M. A., Vidalin, O., Major, M., Trepo, C. & Inchauspe, G. ( 1996; ). Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells. Journal of Clinical Investigation 97, 845-851.[CrossRef]
    [Google Scholar]
  19. Loriot, M. A., Bronowicki, J. P., Lagorce, D., Lakehal, F., Persico, T., Barba, G., Mergey, M., Vons, C., Franco, D., Belghiti, J., Giacca, M., Housset, C. & Bréchot, C. ( 1999; ). Permissiveness of human biliary epithelial cells to infection by hepatitis C virus. Hepatology 29, 1587-1595.[CrossRef]
    [Google Scholar]
  20. Major, M. E. & Feinstone, S. M. ( 1997; ). The molecular virology of hepatitis C. Hepatology 25, 1527-1538.[CrossRef]
    [Google Scholar]
  21. Reed, K. E. & Rice, C. M. ( 2000; ). Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Current Topics in Microbiology and Immunology 242, 55-84.
    [Google Scholar]
  22. Romeo, R., Thiers, V., Driss, F., Berthelot, P., Nalpas, B. & Bréchot, C. ( 1993; ). Hepatitis C virus RNA in serum of blood donors with or without elevated transaminase levels. Transfusion 33, 629-633.[CrossRef]
    [Google Scholar]
  23. Rosa, D., Campagnoli, S., Moretto, C., Guenzi, E., Cousens, L., Chin, M., Dong, C., Weiner, A. J., Lau, J. Y., Choo, Q. L., Chien, D., Pileri, P., Houghton, M. & Abrignani, S. ( 1996; ). A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells. Proceedings of the National Academy of Sciences, USA 93, 1759-1763.[CrossRef]
    [Google Scholar]
  24. Sabile, A., Perlemuter, G., Bono, F., Kohara, K., Demaugre, F., Kohara, M., Matsuura, Y., Miyamura, T., Bréchot, C. & Barba, G. ( 1999; ). Hepatitis C virus core protein binds to apolipoprotein AII and its secretion is modulated by fibrates. Hepatology 30, 1064-1076.[CrossRef]
    [Google Scholar]
  25. Shimizu, Y. K., Hijikata, M., Iwamoto, A., Alter, H. J., Purcell, R. H. & Yoshikura, H. ( 1994; ). Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. Journal of Virology 68, 1494-1500.
    [Google Scholar]
  26. Tanaka, T., Hess, G., Schlueter, V., Zdunek, D., Tanaka, S. & Kohara, M. ( 1999; ). Correlation of interferon treatment response with GBV-C/HGV genomic RNA and anti-envelope 2 protein antibody. Journal of Medical Virology 57, 370-375.[CrossRef]
    [Google Scholar]
  27. van Doorn, L. J., Capriles, I., Maertens, G., DeLeys, R., Murray, K., Kos, T., Schellekens, H. & Quint, W. ( 1995; ). Sequence evolution of the hypervariable region in the putative envelope region E2/NS1 of hepatitis C virus is correlated with specific humoral immune responses. Journal of Virology 69, 773-778.
    [Google Scholar]
  28. Weiner, A. J., Geysen, H. M., Christopherson, C., Hall, J. E., Mason, T. J., Saracco, G., Bonino, F., Crawford, K., Marion, C. D., Crawford, K. A. and others ( 1992; ). Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proceedings of the National Academy of Sciences, USA 89, 3468–3472.[CrossRef]
    [Google Scholar]
  29. Zeuzem, S., Lee, J. H., Franke, A., Ruster, B., Prummer, O., Herrmann, G. & Roth, W. K. ( 1998; ). Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon α. Hepatology 27, 1149-1156.[CrossRef]
    [Google Scholar]
  30. Zhou, Y. H., Moriyama, M. & Esumi, M. ( 1999; ). Multiple sequence-reactive antibodies induced by a single peptide immunization with hypervariable region 1 of hepatitis C virus. Virology 256, 360-370.[CrossRef]
    [Google Scholar]
  31. Zibert, A., Schreier, E. & Roggendorf, M. ( 1995; ). Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208, 653-661.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-83-7-1673
Loading
/content/journal/jgv/10.1099/0022-1317-83-7-1673
Loading

Data & Media loading...

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error